Laurel Grove Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Laurel Grove Capital’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,900	Closed	-$913K	–	101
2016 Q4	$913K	Sell	12,900 -1,750	-12%	-$130K	0.5%	57
2016 Q3	$1.16M	Sell	14,650 -1,900	-11%	-$162K	0.66%	48
2016 Q2	$1.5M	Sell	16,550 -1,300	-7%	-$110K	0.9%	38
2016 Q1	$1.52M	Sell	17,850 -13,800	-44%	-$1.03M	0.86%	42
2015 Q4	$2.5M	Sell	31,650 -500	-2%	-$39.4K	1.4%	29
2015 Q3	$2.26M	Buy	32,150 +12,400	+63%	+$1.02M	1.3%	28
2015 Q2	$1.78M	Hold	19,750	–	–	0.95%	43
2015 Q1	$1.99M	Hold	19,750	–	–	1.06%	37
2014 Q4	$1.99M	Sell	19,750 -2,000	-9%	-$199K	1.13%	37
2014 Q3	$2.09M	Hold	21,750	–	–	1.14%	37
2014 Q2	$2.03M	Buy	21,750 +200	+0.9%	+$17.5K	1.12%	36
2014 Q1	$1.79M	Hold	21,550	–	–	1.08%	39
2013 Q4	$1.8M	Hold	21,550	–	–	1.07%	36
2013 Q3	$1.6M	Buy	+21,550	New	+$1.62M	1.06%	38

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Laurel Grove Capital's MJN Position: Q1 2017 in Review

Laurel Grove Capital sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 12,900 shares — an estimated $913K sold.

Laurel Grove Capital first reported a position in MJN in Q3 2013 and held it in 14 quarters. The position peaked at $2.5M in Q4 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Laurel Grove Capital reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Laurel Grove Capital sold 12,900 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $913K.
Laurel Grove Capital first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 14 quarters.
Laurel Grove Capital's Mead Johnson Nutrition Company position peaked at $2.5M in Q4 2015.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Laurel Grove Capital's 13F filing for Q1 2017, filed 11 Apr 2017.